Jaffre et al_Circulation-2019.pdf Fabrice Jaffré Clint Miller Amy Roberts Anne Schanzer Todd Evans Andreas Hahn Maria I. Kontaridis 10.25376/hra.9624845.v1 https://hra.figshare.com/articles/journal_contribution/Jaffre_et_al_Circulation-2019_pdf/9624845 Here we used iPSC-derived cardiomyocytes and CRISPR-Cas9 to delineate the molecular mechanisms underlying hypertrophic cardiomyopathy in Noonan syndrome individuals with a mutation in RAF1. <br> 2019-08-14 18:24:35 cardiomyocytes ips Noonan syndrome CRSIPR/Cas9 RNA sequencing Signaling pathways Molecular Biology Cardiology